Latest Industry Insights
Industry Insight
Rethinking Chemical Synthesis With Cell-free Biocatalysis
Technology Networks recently had the pleasure of speaking with Debut Bio's CEO Dr Joshua Britton. We discuss the evolution of chemical manufacturing, key challenges faced by those working in the field, and the benefits of combining biocatalysis and continuous manufacturing.
Industry Insight
Data from Direct-to-Consumer Genetic Tests Used To Create a Drug for Inflammatory Diseases
At the beginning of the year, direct-to-consumer (DTC) genetic testing company 23andMe announced that they have generated a bispecific antibody that blocks the IL-36 cytokine family associated with multiple inflammatory diseases. Technology Networks spoke with Christine Pai from 23andMe to find out more.
Industry Insight
Facilitating Cell Culture Growth and Protecting Protein Integrity
Many biotherapeutic drugs such as recombinant antibodies are manufactured utilizing host cells, a common example being Chinese hamster ovary (CHO) cells. A key factor for consideration in this process is the growth and viability of these cells – ultimately this influences the quality and quantity of the biotherapeutic product. Technology Networks spoke with Nicole Wellens, Global Product Manager for BioTherapeutics Media, Lonza to learn more about the new feed and how it has been developed.
Industry Insight
Delving Into Glycogen Storage Diseases
In this interview, Gaia Fancellu, of Iceni Diagnostics, talks about her work in more detail, discusses the challenges of studying GSDs, and highlights the advantages of using a “Systems Medicine” approach to do so.
Industry Insight
Reducing Errors in Whole Genome Sequencing: It Starts With Library Prep
The highly complex process of whole genome sequencing comes with a high cost of error. One pipetting or mixing mistake can lead to costly errors downstream. When working with multiple samples, error-free sample handling and proper mixing becomes even more critical. The first step in the process to prepare the sample for sequencing, library prep, is a vital step that, if not done correctly, can lead to flawed data and costly delays.
Industry Insight
Detecting the Presence of Cancer in Patients’ Breath
Thermo Fisher Scientific and Owlstone Medical have recently entered a collaboration, with the aim of advancing breath diagnostics for the early diagnosis of cancer and other diseases. Dr Max Allsworth, Chief Science Officer, Owlstone Medical, and Dominic Roberts, Product Marketing Manager, Orbitrap GC-MS, Thermo Fisher Scientific tell us more about the collaboration and the advantages that breath biopsies can bring to disease detection.
Industry Insight
Releasing the Handbrake on Endogenous Repair – An Alternative Approach to Treating Alzheimer’s Disease?
Technology Networks recently spoke with Paul Brennan, President and CEO at NervGen Pharma, to gain his insights on why previous attempts to treat Alzheimer's disease have failed, how the novel technology platform NVG-291 works and what promise it holds for AD.
Industry Insight
Motion Capture Trends in Biomechanical Science
In this article, we discuss current examples of how motion capture technology can be applied across the life sciences industry.
Industry Insight
Ensuring Reliable Material Identification in Pharmaceutical Manufacturing
Variability in the quality of raw materials can not only impact production yields, but can also affect the quality, efficacy and safety of the final pharmaceutical product. In this interview, learn about how the capabilities of two handheld analyzers ensure reliable material identity verification.
Industry Insight
Using Protein Biomarkers Increases the Chances of Success in Clinical Trials
Many clinical trials fail due to lack of efficacy. But while some of this may be due to poor target selection during the drug discovery process, it’s becoming increasingly clear that only certain patients respond to treatments. So how exactly does precision medicine increase the likelihood of success in clinical trials?
Advertisement